Does anticholinergic medication have a role for men with lower urinary tract symptoms/benign prostatic hyperplasia either alone or in combination with other agents?
- 1 January 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Urology
- Vol. 14 (1) , 13-16
Abstract
A substantial proportion of men with lower urinary tract symptoms have a combination of both 'storage' and 'voiding' symptoms, suggesting possible coexisting bladder outlet obstruction and bladder overactivity. Bladder overactivity is traditionally treated with anticholinergic drugs. However, guidelines from the European Association of Urologists make no mention of the possible therapeutic role of anticholinergic drugs for treating storage symptoms in such patients. It is a common perception that using an anticholinergic drug in men with bladder outlet obstruction runs the risk of inducing acute urinary retention, because of the inhibitory effect of anticholinergics on bladder contraction in the presence of outlet obstruction. This review focuses on recent data determining the efficacy of anticholinergic medication in men with lower urinary tract symptoms/benign prostatic hyperplasia and the associated risk of acute urinary retention. One recent study in men with urodynamically confirmed obstruction supports the assertion that anticholinergic drugs are safe in men with bladder outlet obstruction. Safety data from larger studies using anticholinergics in patients with overactive bladders supports these findings. Efficacy and safety studies of anticholinergic medication in men with lower urinary tract symptoms/benign prostatic hyperplasia are few and far between, but preliminary data suggests they are not associated with a substantial risk of urinary retention nor with a substantial increase in residual urine volume.Keywords
This publication has 7 references indexed in Scilit:
- Combination Treatment With an α-Blocker Plus an Anticholinergic for Bladder Outlet Obstruction: A Prospective, Randomized, Controlled StudyJournal of Urology, 2003
- Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic reviewBMJ, 2003
- Safety of tolterodine in men with Bladder Outlet Obstruction (BOO) and symptomatic detrusor overactivityEuropean Urology Supplements, 2002
- TOLTERODINE: SUPERIOR TOLERABILITY THAN AND COMPARABLE EFFICACY TO OXYBUTYNIN IN INDIVIDUALS 50 YEARS OLD OR OLDER WITH OVERACTIVE BLADDER: A RANDOMIZED CONTROLLED TRIALJournal of Urology, 2001
- Introduction: overactive bladder and its treatmentsUrology, 2000
- CORRELATION BETWEEN THE STRUCTURE AND FUNCTION OF THE RABBIT URINARY BLADDER FOLLOWING PARTIAL OUTLET OBSTRUCTIONJournal of Urology, 2000
- Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety dataUrology, 1999